LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer

Table 1 The relationship between the expression of BC069792 in breast cancer and the clinicopathological parameters of patients

Clinical parameter	Quantity	BC069792		Chi-square test
Clinical parameter	Quantity	LOW expression	High expression	x2	P, price
age				1.951	0.162
< 65	78	59	19
≥ 65	20	12	8
pathological grading				8.120	0.004
I	18	7	11
II + III	80	59	21
tumor size				1.395	0.238
< 2 cm	26	3	23
≥ 2 cm	72	16	56
Hemorrhage, calcification, necrosis, and cyst change				3.623	0.057
NO	43	11	32
YES	55	6	49
lymphatic metastasis^a				10.324	0.001
NO	54	18	36
YES	37	25	12
Out-67 index					0.045
< 30%	36	0	36
≥ 30%	62	7	55

^aSeven cases were not tested for lymph node metastasis. Inspection level a = 0.05

ISSN: 1476-4598